Description
After blood collection, the patient’s circulating tumor cells (CTC) are expanded with exclusive culture technology. This allows physicians to conduct customized drug sensitivity testing with the patient’s tumor avatar before treatment selection. Our technology helps physicians find treatments for their patients in a timely manner and reduce the risk of drug resistance. This not only shortens the time delayed in trying different therapies but also reduces the risk of side effects for patients who have not found an effective drug.
◎ To know more about circulating tumor cells, please refer to this article.
★ Applicable cancer types: all solid tumors, such as lung cancer, breast cancer, colorectal cancer, prostate cancer, ovarian cancer, liver cancer, stomach cancer, pancreatic cancer, kidney cancer, bladder cancer, skin cancer, sarcoma, brain cancer, etc., or various rare cancer.
★ Acceptance conditions: diagnosed with solid tumor stage 2 or above.
★ Specimen requirement: 20mL blood
★ Advantage
– Only blood sample is needed, easy to collect, suitable for elderly patients and patients who are difficult to obtain tissue samples.
– Blood samples are more homogeneous, and more representative than local tissue samples if the tumor has distant metastasis
– Fully customized drug list
Reviews
There are no reviews yet.